Homrich & Berg’s CervoMed CRVO Stock Holding History

Homrich & Berg’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$5K	Hold	133	–	–	﹤0.01%	476
2021 Q2	$7K	Buy	+133	New	+$7.35K	﹤0.01%	489

Other funds holding CRVO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Yu Fan $97M AUM 57.2% 1-Year Est. Return

WSTAM

Wilbanks Smith & Thomas Asset Management Norfolk, Virginia $3.57B AUM 21.11% 1-Year Est. Return

Homrich & Berg's CRVO Position: Q3 2021 in Review

Homrich & Berg held its CervoMed (CRVO) position steady in Q3 2021 at 133 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #476.

Homrich & Berg first reported a position in CRVO in Q2 2021 and has held it in 2 quarters since. The position peaked at $7K in Q2 2021. 24 funds tracked by Wall St. Rank hold CRVO as of Q3 2021.

Homrich & Berg held 133 shares of CervoMed worth $5K as of Q3 2021.
Homrich & Berg left its CervoMed share count unchanged in Q3 2021.
CervoMed made up ﹤0.01% of Homrich & Berg's portfolio in Q3 2021, its #476 holding.
Homrich & Berg first reported a position in CervoMed in Q2 2021 and has held it in 2 quarters since.
Homrich & Berg's CervoMed position peaked at $7K in Q2 2021.
24 funds tracked by Wall St. Rank held CervoMed as of Q3 2021.

Based on Homrich & Berg's 13F filing for Q3 2021, filed 8 Dec 2021.